-
3
-
-
0036284490
-
-
Aslo see
-
Aslo see. Miknyoczki S.J., Wan W., Chang H., Dobrzanski P., Ruggeri B.A., Dionne C.A., and Buchkovich K. Clin. Cancer Res. 8 (2002) 1924
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 1924
-
-
Miknyoczki, S.J.1
Wan, W.2
Chang, H.3
Dobrzanski, P.4
Ruggeri, B.A.5
Dionne, C.A.6
Buchkovich, K.7
-
4
-
-
38449108441
-
-
Liu D., Zhang Y., Dang C., Ma Q., Lee W., and Chen W. Oncol. Rep. 18 (2007) 673
-
(2007)
Oncol. Rep.
, vol.18
, pp. 673
-
-
Liu, D.1
Zhang, Y.2
Dang, C.3
Ma, Q.4
Lee, W.5
Chen, W.6
-
7
-
-
33845982229
-
-
Campos X., Muñoz Y., Selman A., Yazigi R., Moyano L., Weinstein-Oppenheimer C., Lara H.E., and Romero C. Gynecol. Oncol. 104 (2007) 168
-
(2007)
Gynecol. Oncol.
, vol.104
, pp. 168
-
-
Campos, X.1
Muñoz, Y.2
Selman, A.3
Yazigi, R.4
Moyano, L.5
Weinstein-Oppenheimer, C.6
Lara, H.E.7
Romero, C.8
-
9
-
-
0742304068
-
-
Davidson B., Reich R., Lazarovici P., Ann F.V., Nielsen S., and Nesland J.M. Breast Cancer Res. Treat. 83 (2004) 119
-
(2004)
Breast Cancer Res. Treat.
, vol.83
, pp. 119
-
-
Davidson, B.1
Reich, R.2
Lazarovici, P.3
Ann, F.V.4
Nielsen, S.5
Nesland, J.M.6
-
10
-
-
33846466432
-
-
Perez-Pinera P., Hernandez T., Garci{dotless}́a-Suárez O., de Carlos F., Germana A., Del V.M., Astudillo A., and Vega J.A. Mol. Cell. Biochem. 295 (2007) 19
-
(2007)
Mol. Cell. Biochem.
, vol.295
, pp. 19
-
-
Perez-Pinera, P.1
Hernandez, T.2
García-Suárez, O.3
de Carlos, F.4
Germana, A.5
Del, V.M.6
Astudillo, A.7
Vega, J.A.8
-
15
-
-
33746614110
-
-
Lippa B., Morris J., Corbett M., Kwan T.A., Noe M.C., Snow S.L., Gant T.G., Mangiaracina M., Coffey H.A., Foster B., Knauth E.A., and Wessel M.D. Bioorg. Med. Chem. Lett. 16 (2006) 3444
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 3444
-
-
Lippa, B.1
Morris, J.2
Corbett, M.3
Kwan, T.A.4
Noe, M.C.5
Snow, S.L.6
Gant, T.G.7
Mangiaracina, M.8
Coffey, H.A.9
Foster, B.10
Knauth, E.A.11
Wessel, M.D.12
-
16
-
-
0842302965
-
-
Wood E.R., Kuyper L., Kimberly G.P., Hunter III R.N., Harris P.A., and Lackey K. Bioorg. Med. Chem. Lett. 14 (2004) 953
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 953
-
-
Wood, E.R.1
Kuyper, L.2
Kimberly, G.P.3
Hunter III, R.N.4
Harris, P.A.5
Lackey, K.6
-
20
-
-
0242268455
-
-
For X-ray and mode of interaction with kinases see and references there in
-
For X-ray and mode of interaction with kinases see. Schiering N., Knapp S., Marconi M., Flocco M.M., Cui J., Perego R., Rusconi L., and Cristiani C. Proc. Natl. Acad. Sci. U.S.A. 22 (2003) 12654 and references there in
-
(2003)
Proc. Natl. Acad. Sci. U.S.A.
, vol.22
, pp. 12654
-
-
Schiering, N.1
Knapp, S.2
Marconi, M.3
Flocco, M.M.4
Cui, J.5
Perego, R.6
Rusconi, L.7
Cristiani, C.8
-
21
-
-
44849091074
-
-
For a discussion in the lack of selectivity see
-
For a discussion in the lack of selectivity see. Tamaoki T., and Nomoto H. Biochemistry 8 (1990) 732
-
(1990)
Biochemistry
, vol.8
, pp. 732
-
-
Tamaoki, T.1
Nomoto, H.2
-
23
-
-
34250378582
-
-
Festuccia C., Muzi P., Gravina G.L., Millimaggi D., Speca S., Dolo V., Ricevuto E., and Bologna M. Int. J. Oncol. 30 (2007) 193
-
(2007)
Int. J. Oncol.
, vol.30
, pp. 193
-
-
Festuccia, C.1
Muzi, P.2
Gravina, G.L.3
Millimaggi, D.4
Speca, S.5
Dolo, V.6
Ricevuto, E.7
Bologna, M.8
-
24
-
-
0033563119
-
-
George D.J., Dionne C.A., Jani J., Angeles T., Murakata C., Lamb J., and Isaacs J.T. Cancer Res. 59 (1999) 2395
-
(1999)
Cancer Res.
, vol.59
, pp. 2395
-
-
George, D.J.1
Dionne, C.A.2
Jani, J.3
Angeles, T.4
Murakata, C.5
Lamb, J.6
Isaacs, J.T.7
-
25
-
-
0032771840
-
-
Miknyoczki S.J., Chang H., Klein-Szanto A.J., Dionne C.A., and Ruggeri B.A. Clin. Cancer Res. 5 (1999) 2205
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 2205
-
-
Miknyoczki, S.J.1
Chang, H.2
Klein-Szanto, A.J.3
Dionne, C.A.4
Ruggeri, B.A.5
-
26
-
-
20844444589
-
-
Marshall J.L., Kindler H., Deeken J., Bhargava P., Vogelzang N.J., Rizvi N., Luhtala T., and Ratain M.J. Investig. New Drugs 23 (2005) 31
-
(2005)
Investig. New Drugs
, vol.23
, pp. 31
-
-
Marshall, J.L.1
Kindler, H.2
Deeken, J.3
Bhargava, P.4
Vogelzang, N.J.5
Rizvi, N.6
Luhtala, T.7
Ratain, M.J.8
-
27
-
-
0037033230
-
-
Tripathy R., Learn K.S., Reddy D.R., Iqbal M., Singh J., and Mallamo J.P. Tetrahedron Lett. 43 (2002) 217
-
(2002)
Tetrahedron Lett.
, vol.43
, pp. 217
-
-
Tripathy, R.1
Learn, K.S.2
Reddy, D.R.3
Iqbal, M.4
Singh, J.5
Mallamo, J.P.6
-
28
-
-
44849113993
-
-
For the design and synthesis of 4a see Hudkins, R. L.; Knight, E. Jr. US Patent 5, 705, 511.
-
For the design and synthesis of 4a see Hudkins, R. L.; Knight, E. Jr. US Patent 5, 705, 511.
-
-
-
-
29
-
-
10744227153
-
-
For a nomenclature of 4a see
-
For a nomenclature of 4a see. Gingrich D.E., Reddy D.R., Iqbal M.A., Singh J., Aimone L.D., Angeles T.S., Albom M., and Hudkins R.L. J. Med. Chem. 46 (2003) 5375
-
(2003)
J. Med. Chem.
, vol.46
, pp. 5375
-
-
Gingrich, D.E.1
Reddy, D.R.2
Iqbal, M.A.3
Singh, J.4
Aimone, L.D.5
Angeles, T.S.6
Albom, M.7
Hudkins, R.L.8
-
30
-
-
0030002415
-
-
Angeles T.S., Steffler C., Bartlett B.A., Hudkins R.L., Stephens R.M., Kaplan D.R., and Dionne C.A. Anal. Biochem. 236 (1996) 49
-
(1996)
Anal. Biochem.
, vol.236
, pp. 49
-
-
Angeles, T.S.1
Steffler, C.2
Bartlett, B.A.3
Hudkins, R.L.4
Stephens, R.M.5
Kaplan, D.R.6
Dionne, C.A.7
-
31
-
-
44849114496
-
-
2, 0.1% BSA, 2.5% DMSO, and various concentrations of test compound was added to the plate. The reaction was initiated by adding recombinant human TrkA kinase and was allowed to proceed at 37 °C for 15 min. The primary antibody, N1 europium-labeled anti-phosphotyrosine (PT66) antibody (Wallac # AD0041), was then added to detect the reaction product (phosphorylated PLC-γ/GST). After 1-h incubation at 37 °C, enhancement solution (Wallac # 1244-105) was added
-
50 values were calculated by nonlinear regression using the sigmoidal dose-response (variable slope) equation in GraphPad Prism.
-
-
-
-
32
-
-
0034651237
-
-
TrkA intact cell assay: The inhibition of NGF-stimulated phosphorylation of trk was performed as described in 15c. Briefly, subconfluent NIH3T3-TrkA (positive control) and NIH3T3-vector (negative control) cells were treated with test compounds for 1 h at 37 °C. After stimulation with NGF for 5 min, the cells were rinsed with ice-cold PBS, and then lysed with lysis buffer containing 1 mM activated sodium vanadate. Clarified cell lysates corresponding to equal amounts of protein were then immunoprecipitated with anti-trk antibody (CEP-21) for 1 h, followed by incubation with Protein A-Sepharose for another hours at 4 °C. Immunoprecipitates were analyzed on a 7.5% SDS-polyacrylamide gel, and then transferred onto a Millipore PVDF membrane. The membrane was immunoblotted with 4G10 anti-phosphotyrosine antibody, followed by incubation with HRP-coupled goat anti-mouse IgG.
-
Angeles T.S., Lippy J.S., and Yang S.X. Anal. Biochem. 278 (2000) 93 TrkA intact cell assay: The inhibition of NGF-stimulated phosphorylation of trk was performed as described in 15c. Briefly, subconfluent NIH3T3-TrkA (positive control) and NIH3T3-vector (negative control) cells were treated with test compounds for 1 h at 37 °C. After stimulation with NGF for 5 min, the cells were rinsed with ice-cold PBS, and then lysed with lysis buffer containing 1 mM activated sodium vanadate. Clarified cell lysates corresponding to equal amounts of protein were then immunoprecipitated with anti-trk antibody (CEP-21) for 1 h, followed by incubation with Protein A-Sepharose for another hours at 4 °C. Immunoprecipitates were analyzed on a 7.5% SDS-polyacrylamide gel, and then transferred onto a Millipore PVDF membrane. The membrane was immunoblotted with 4G10 anti-phosphotyrosine antibody, followed by incubation with HRP-coupled goat anti-mouse IgG. Phosphorylated bands were visualized by enhanced chemiluminescence. Cell score as measured by a densitometer: 0 = no decrease; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%; 4 = 76-100%
-
(2000)
Anal. Biochem.
, vol.278
, pp. 93
-
-
Angeles, T.S.1
Lippy, J.S.2
Yang, S.X.3
-
33
-
-
44849142238
-
-
50 values (data not shown). With few exceptions (most likely due to cell permeability or solubility), a good correlation was observed between the enzyme and cell activities of the Staurosporine-like molecules described here.
-
50 values (data not shown). With few exceptions (most likely due to cell permeability or solubility), a good correlation was observed between the enzyme and cell activities of the Staurosporine-like molecules described here.
-
-
-
-
34
-
-
44849113653
-
-
note
-
Since the nature of the substrate controls the pi-facial selectivity for our system, diastereomeric ratios were obtained in the range of ∼1:1 to 85:15. In some cases reversal in facial selectivity were also noticed (see Ref. 14a).
-
-
-
-
35
-
-
20144381281
-
-
It has been shown that the (3′S)-epi-K-252a with an altered orientation of the free hydroxyl group of the sugar is 11-fold more potent for TrkA kinase than K-252a, indicting the importance of the orientation the hydroxyl group toward TrkA kinase activity and selectivity
-
It has been shown that the (3′S)-epi-K-252a with an altered orientation of the free hydroxyl group of the sugar is 11-fold more potent for TrkA kinase than K-252a, indicting the importance of the orientation the hydroxyl group toward TrkA kinase activity and selectivity. Gingrich D.E., Yang S.X., Gessner G.W., Angeles T.S., and Hudkins R.L. J. Med. Chem. 48 (2005) 3776
-
(2005)
J. Med. Chem.
, vol.48
, pp. 3776
-
-
Gingrich, D.E.1
Yang, S.X.2
Gessner, G.W.3
Angeles, T.S.4
Hudkins, R.L.5
-
37
-
-
17544387877
-
-
Such longer chain of the inhibitor could reach a non-ATP site of the kinase, which in turn would enhance the selectivity. Similar binding proposition has been made. For example, see the modeling results for PKA
-
Such longer chain of the inhibitor could reach a non-ATP site of the kinase, which in turn would enhance the selectivity. Similar binding proposition has been made. For example, see the modeling results for PKA. Hennequin L.F., Thomas A.P., Johnstone C., Stokes E.S.E., Ple P.A., Lohmann J.-J., Ogilvie D.J., Dukes M., Wedge S.R., Curwen J.O., Kendrew J., and Lambert-van der Brempt C.J. J. Med. Chem. 42 (1999) 5369
-
(1999)
J. Med. Chem.
, vol.42
, pp. 5369
-
-
Hennequin, L.F.1
Thomas, A.P.2
Johnstone, C.3
Stokes, E.S.E.4
Ple, P.A.5
Lohmann, J.-J.6
Ogilvie, D.J.7
Dukes, M.8
Wedge, S.R.9
Curwen, J.O.10
Kendrew, J.11
Lambert-van der Brempt, C.J.12
|